Therefore, over the course of the 30 h infection, dynamic changes, including metabolization (e.g., to Sph by acid ceramidases [ASAH1], or SM by SMase [SMPD1]) can affect the outcome of our end-point analysis. This evidence concerns the gene ASAH1 and infection.